Here we report that neuropeptide S (NPS) signaling in the PVT is necessary for stimulus salience encoding

Thomas P.

biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company

The Author(s), under exclusive licence to Springer Nature America, Inc." Authors Victoria H Wu , Bryan S Yung , Farhoud Faraji , Robert Saddawi-Konefka , Zhiyong Wang , Alexander T Wenzel , Miranda J Song , Meghana S Pagadala , Lauren M Clubb , Joshua Chiou , Sanju Sinha , Marin Matic , Francesco Raimondi , Thomas S Hoang , Rebecca Berdeaux , Dario A A Vignali , Ramiro Iglesias-Bartolome

Thomas P. Sakmar About Dr. Thomas P. dynamics simulations and coarse-grain sampling approaches for membrane proteins in collaborations with Thomas Thomas P.

Thomas Sakmar’s laboratory at Rockefeller University, where she studies the signaling and degradation started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined the lab of Thomas